Literature DB >> 29134665

Mechanistic contributions of FBXO7 to Parkinson disease.

Sabitha Joseph1, Jörg Bernhard Schulz1,2, Judith Stegmüller1.   

Abstract

Parkinson disease (PD) is, without doubt, a burden on modern society as the prevalence increases significantly with age. Owing to this growing number of PD cases, it is more critical than ever to understand the pathogenic mechanisms underlying PD to identify therapeutic targets. The discovery of genetic mutations associated with PD and parkinsonism paves the way toward this goal. Even though, familial forms of the disease represent the minority of PD cases and some forms are so rare that there are only a few affected families, the research on the associated genes is invaluable. Recent additions to PARK mutations are those in PARK15 that encodes the F-box protein O-type 7 (FBXO7). In this review, we highlight the recent research on FBXO7, which advances our knowledge of the etiopathological pathways and fills unexpected gaps therein, justifying the dedicated study of rare variants of PD.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  FBXO7; Parkinson disease; mitochondria; parkinsonism; ubiquitin proteasome system

Mesh:

Substances:

Year:  2017        PMID: 29134665     DOI: 10.1111/jnc.14253

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  Myelinating Glia-Specific Deletion of Fbxo7 in Mice Triggers Axonal Degeneration in the Central Nervous System Together with Peripheral Neuropathy.

Authors:  Sabitha Joseph; Siv Vingill; Olaf Jahn; Robert Fledrich; Hauke B Werner; Istvan Katona; Wiebke Möbius; Mišo Mitkovski; Yuhao Huang; Joachim Weis; Michael W Sereda; Jörg B Schulz; Klaus-Armin Nave; Judith Stegmüller
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

Review 2.  The Emerging Roles of E3 Ligases and DUBs in Neurodegenerative Diseases.

Authors:  Na Liu; Miao-Miao Lin; Yan Wang
Journal:  Mol Neurobiol       Date:  2022-10-19       Impact factor: 5.682

Review 3.  The Potential Role of Astrocytes in Parkinson's Disease (PD).

Authors:  Hiluf Hindeya Gebreyesus; Teklu Gebrehiwot Gebremichael
Journal:  Med Sci (Basel)       Date:  2020-01-27

Review 4.  Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis.

Authors:  Stefanie Smolders; Christine Van Broeckhoven
Journal:  Acta Neuropathol Commun       Date:  2020-05-06       Impact factor: 7.801

Review 5.  Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era.

Authors:  Dunhui Li; Frank L Mastaglia; Sue Fletcher; Steve D Wilton
Journal:  Med Res Rev       Date:  2020-08-06       Impact factor: 12.944

Review 6.  PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson's Disease.

Authors:  Wen Li; YuHong Fu; Glenda M Halliday; Carolyn M Sue
Journal:  Front Cell Dev Biol       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.